Revvity Inc vs Royal Bank of Canada — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Royal Bank of Canada trades at $210.37 (market cap $289.51B). The key difference: Royal Bank of Canada is far larger — about 24.4× Revvity Inc's market cap, and Royal Bank of Canada pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| RVTY | RY | |
|---|---|---|
Market Cap | $11.87B | $289.51B |
Sector | Technology | Financials |
52-Week High | $117.75 | $217.87 |
52-Week Low | $82.26 | $128.46 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | 2.42% |
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →